Need help? Start a web chat with one of our pharmacists or our customer service representatives now!
HOURS OF OPERATION:
Monday to Thursday
8 AM to 5 PM (CST)
Friday
8 AM to 4 PM (CST)
Strattera {Lilly}
atomoxetine, pronounced AT oh mox e teen
Strattera is a medication used to treat attention deficit hyperactivity disorder, also known as ADHD, in adults and children age six and older. Strattera works by affecting the chemicals in your brain that contribute to hyperactivity and impulse control.
Strattera may also be used for reasons not stated in this medication guide.
You should not take Strattera if you are currently taking thioridazine (Mellaril), or an MAO inhibitor like furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate). You could suffer from a dangerous drug interaction if you take any of the above medications along with Strattera. You should wait at least 14 days after stopping an MAO inhibitor before starting treatment with Strattera.
Strattera can cause sudden death in children and adolescents with serious heart problems or congenital heart defects. Tell your doctor if you or your child has any type of heart problem before he or she begins taking Strattera.
Strattera may slow a child’s growth. Talk to your doctor if your child is taking Strattera and is not growing as expected.
You should not drink alcohol while taking Strattera, as it may increase certain side effects of this medication.
Be aware that Strattera may impair your reactions or thinking. You should be careful when driving or doing anything which requires you to be alert, especially when you first start taking Strattera.
You should be aware of any mood or behavior changes while you are taking Strattera. If you have suicidal thoughts, depression, or thoughts of hurting yourself you should tell your doctor immediately.
Tell your doctor if you are pregnant or plan to become pregnant. Strattera is in FDA pregnancy category C. It is not known that if Strattera may cause problems in your newborn. Consult with your doctor if you become pregnant while taking Strattera. You should not breastfeed while taking Strattera, as we do not know if Strattera can pass into breast milk and may harm a nursing baby.
If you are allergic to atomoxetineyou should not take Strattera.
You should not take Strattera if you are currently taking thioridazine (Mellaril), or an MAO inhibitor like furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate). You could suffer from a dangerous drug interaction if you take any of the above medications along with Strattera. You should wait at least 14 days after stopping an MAO inhibitor before starting treatment with Strattera.
If you have glaucoma or pheochromocytoma (a tumor of the adrenal gland) you should not take Strattera.
Let your doctor know if you have a congenital heart defect, heart disease, a heart rhythm disorder, coronary artery disease, a history of stroke or blood clots, or high or low blood pressure. These conditions may be a reason you should not take Strattera.
You should tell your doctor if you have recently had a heart attack before taking Strattera, or if anyone in your family has died suddenly from a heart condition.
If you have liver disease, a family or personal history of mental illness such as bipolar disorder or depression, or if you have problems urinating you should tell your doctor before taking Strattera.
Strattera is not meant to be a long-term use drug to treat ADHD. Your doctor may recommend another medication for you to take long-term to treat your condition.
Treatment with Strattera is not to be used for patients under age six (6).
You should inform your doctor if you are taking any of the following:
Other drugs you take that are not listed may interact with Strattera. You should tell your doctor about all of the medications you use. This includes prescription drugs, vitamins, supplements and herbal products, and over the counter medications. You should not begin taking a new medication without telling your doctor first.
You should take Strattera exactly as directed by your doctor. It is important that you do not take Strattera in larger or smaller amounts, or for longer or shorter than recommended. Follow the directions on your prescription label and follow any dose changes carefully if your doctor instructs you to change your dose.
Strattera may be taken with or without food.
You should take Strattera with a full glass of water.
Strattera is typically taken once a day, but your doctor may instruct you to take it twice a day, once in the morning and once in the late afternoon.
You should not use a capsule that has been opened or broken. The medicine from inside the Strattera capsule can be dangerous if it gets in your eyes. Your doctor or pharmacist can tell you how to safely handle and dispose of a broken or opened capsule.
Strattera needs to be stored at room temperature, and away from light, moisture and heat. Keep your bottle tightly closed when you are not using it.
If you miss a dose of Strattera you should attempt to take the missed dose as soon as you remember. However, if it is almost time for your next scheduled dose do not take the missed dose in addition to your regular dose.
If you experience any of the following adverse effects you should stop taking Strattera and seek emergency medical help immediately:
Less serious side effects of Strattera may include:
It should be noted that this is not a complete list of possible side effects of Strattera. You should contact your physician for a complete list and medical advice regarding these effects.
Strattera is available in capsule form in the following doses:
10 mg opaque white imprinted with LILLY 3227
18 mg gold and opaque white imprinted with LILLY 3238
25 mg opaque blue and opaque white imprinted with LILLY 3228
40 mg opaque blue imprinted with LILLY 3229
60 mg opaque blue and gold imprinted with LILLY 3239
80 mg opaque brown and opaque white imprinted with LILLY 3250
100 mg opaque brown imprinted with LILLY 3251
You should consult your doctor for specific dosing pertaining to you. Do not attempt to alter or change your dose without your physician’s consent.
If you suspect that you have overdosed with Strattera you should seek emergency help immediately.
Strattera is comprised of the main ingredient atomoxetine HCl. Other ingredients include pregelatinized starch and dimethicone. The capsule shells contain gelatin, sodium lauryl sulfate and one or more of the following: FD&C Blue No. 2, synthetic yellow iron oxide, titanium dioxide or red iron oxide. The capsules are imprinted with edible black ink.
The information contained in this drug guide is intended as an educational resource only. This guide is not exhaustive and does not contain all available information about this drug.This guide is not intended as medical advice for individual conditions or treatment.
The information provided in this guide does not replace the need for the advice and services of medical professionals or the need for medical examination. Always talk to your physician or pharmacist before taking any prescription medication or over the counter drugs (including any supplements) or before making any changes to your treatment. Only your doctor, nurse or pharmacist can provide you with safe and effective advice regarding your drug treatment.
The use of the information in this guide is at your sole risk. This information is provided "AS IS" with no warranties to accuracy or timeliness.
**All trademarks and registered trademarks are the property of their respective owners.